In Brief: Cardiac Pacemakers, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Cardiac Pacemakers, Inc.: Guidant unit receives FDA approval for its Ventak P3 automatic implantable cardioverter defibrillator. The P3 is a shock-only version of the company's Ventak PRxIII tiered-therapy defibrillator, which received FDA's nod in May ("The Gray Sheet" May 8, In Brief). Guidant says the P3 offers the same therapy features as its earlier-version Ventak P2 shock-only device, but is 30% smaller in size...